RS261336 Unknown gene
Upload your DNA to see your genotype for this variant.
What This Variant Does
"Impact of geneticfactorsondyslipidemia in HIV-infected patients starting antiretroviral therapy"
GWAS Studies (14)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Phosphatidylcholine_33:4_[M+H]1+/Phosphatidylethanolamine_36:4_[M+H]1+/Phosphatidate_38:5_[M+NH4]1+ levels | G | OR: 0.28 | 4E-67 | PubMed |
| Phosphatidylcholine_35:4_[M+H]1+/Phosphatidylethanolamine_38:4_[M+H]1+/Phosphatidate_40:5_[M+NH4]1+ levels | G | OR: 0.26 | 4E-61 | PubMed |
| Phosphatidylethanolamine_38:6_[M-H]1- levels | G | OR: 0.26 | 1E-60 | PubMed |
| Phosphatidylethanolamine_36:4_[M-H]1- levels | G | OR: 0.24 | 9E-54 | PubMed |
| Phosphatidylcholine_35:6_[M+H]1+/Phosphatidylethanolamine_38:6_[M+H]1+/Phosphatidate_40:7_[M+NH4]1+ levels | G | OR: 0.25 | 3E-51 | PubMed |
| Phosphatidylcholine_31:2_[M+H]1+/Phosphatidylethanolamine_34:2_[M+H]1+/Phosphatidate_36:3_[M+NH4]1+ levels | G | OR: 0.23 | 3E-42 | PubMed |
| Phosphatidylethanolamine_34:2_[M-H]1- levels | G | OR: 0.18 | 2E-29 | PubMed |
| Phosphatidylcholine_37:6_[M+H]1+/Phosphatidylethanolamine_40:6_[M+H]1+/Phosphatidate_42:7_[M+NH4]1+ levels | G | OR: 0.21 | 7E-26 | PubMed |
| Multi-trait sum score | — | — | 6E-24 | PubMed |
| Multi-trait sex score | — | — | 4E-22 | PubMed |
| Phosphatidylethanolamine_38:5_[M-H]1- levels | G | OR: 0.11 | 1E-15 | PubMed |
| Phosphatidylethanolamine_36:3_[M-H]1- levels | G | OR: 0.11 | 5E-15 | PubMed |
| High density lipoprotein cholesterol levels | C | OR: 2.25 | 4E-14 | PubMed |
| Lysophosphatidylethanolamine_16:0_[M-H]1- levels | G | β: 0.096 | 7E-11 | PubMed |